Diabetes update to NICE guidelines

NICE, the National Institute for Health and Clinical Excellence have changed what they recommend for treating type 2 diabetes under the National Health Service . The new diabetes guidelines include the use of DPP-4 inhibitors.
DPP-4 inhibitors are a class of diabetes drugs that are in wide use. Applied when metformin fails to help control blood sugar levels, the drugs are used as a second-line therapy amongst those who face a strong risk of hypoglycaemia or cannot take metformin.
The NICE advises people with type 2 diabetes to focus on a healthy lifestyle, blood pressure and lipid levels controls, and lowering the amount of blood glucose . Professor Anthony Barnett was reported as commenting: “One of the key issues when considering treatment options is striking a balance of achieving optimal glycaemic control while also minimising the risk of hypoglycaemia.”